Higher Expression of Whole Blood MicroRNA-21 in Patients with Ankylosing Spondylitis Associated with Programmed Cell Death 4 mRNA Expression and Collagen Cross-linked C-telopeptide Concentration

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Rheumatology

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.130515PMID 24786924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer

  2013cited by this paper
• Down‐regulation of miR‐21 biogenesis by estrogen action contributes to osteoclastic apoptosis

  2013cited by this paper
• Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• MicroRNA biogenesis and regulation of bone remodeling

  2011cited by this paper
• Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

  2011cited by this paper
• A microRNA expression signature of osteoclastogenesis.

  2011cited by this paper
• Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis

  2011cited by this paper
• Analysis of circulating microRNA: preanalytical and analytical challenges.

  2011cited by this paper
• Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.

  2010cited by this paper
• MicroRNA in erythrocytes.

  2010cited by this paper
• Pathogenesis of ankylosing spondylitis

  2010cited by this paper
• Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment

  2010cited by this paper
• Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

  2009cited by this paper
• Structural basis for translational inhibition by the tumour suppressor Pdcd4

  2009cited by this paper
• MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression 1

  2009cited by this paper
• The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis

  2009cited by this paper
• Bone Remodeling

  2008cited by this paper
• Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

  2008cited by this paper
• MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

  2008cited by this paper
• miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism.

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan

  2007cited by this paper
• Ankylosing spondylitis.

  2007cited by this paper
• Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies.

  2006cited by this paper
• Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials.

  2006cited by this paper
• Bone Remodeling

  2006cited by this paper
• Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

  2004cited by this paper
• International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

  2003cited by this paper
• Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

  2001cited by this paper
• The detection of the HLA-B27 antigen by immunomagnetic separation and enzyme-linked immunosorbent assay-comparison with a flow cytometric procedure.

  2001cited by this paper
• Changes in Bone Density in Patients with Ankylosing Spondylitis: A Two-Year Follow-Up Study

  2001cited by this paper
• Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy

  2000cited by this paper
• Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium.

  1997cited by this paper
• Are classification criteria for spondylarthropathy useful as diagnostic criteria?

  1995cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper
• The pathogenesis of ankylosing spondylitis.

  1975cited by this paper
• Ankylosing spondylitis and HL-A 27.

  1973cited by this paper
• Ankylosing Spondylitis

  1955cited by this paper

• The inhibition of miR-125b-5P prevented Treg differentiation through activating STAT3/HIF-1α pathway in PBMCs of ankylosing spondylitis.

  2026cites this paper
• Acupuncture Treatment May Improve the Bone Metabolism and Pathological Ossification by Regulating the Gut Microbiota of AS Mice.

  2025cites this paper
• Oxidative Phosphorylation Pathway in Ankylosing Spondylitis: Multi‐Omics Analysis and Machine Learning

  2025cites this paper
• miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markers.

  2024cites this paper
• Spinal cord injury dysregulates fibro-adipogenic progenitors miRNAs signaling to promote neurogenic heterotopic ossifications

  2023cites this paper
• The study of the effect of HLA‐B27 on THP‐1 monocytic cells survival and its mechanism

  2023cites this paper
• Differentially expressed protein‐coding genes in ankylosing spondylitis: Emerging insights into pathogenesis and therapeutic approaches

  2023cites this paper
• Association of vascular endothelial growth factor serum levels with ankylosing spondylitis in Egyptian patients

  2023cites this paper
• Genetic factors involved in the co‑occurrence of endometriosis with ankylosing spondylitis (Review)

  2023cites this paper
• Role of MicroRNAs in Inflammatory Joint Diseases: A Review

  2023cites this paper
• A case report of primary biliary cholangitis combined with ankylosing spondylitis

  2023cites this paper
• The role of miRNAs in Behçet’s disease

  2023cites this paper
• Micrornas In The Pathogenesis Of Ankylosing Spondylitis And Their Clinical Implication.

  2022cites this paper
• Identification of diagnostic mRNA biomarkers in whole blood for ankylosing spondylitis using WGCNA and machine learning feature selection

  2022cites this paper
• MicroRNAs as Biomarkers for the Diagnosis of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis

  2021cites this paper
• Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors

  2021cites this paper
• Gut microbiota-microRNA interactions in ankylosing spondylitis.

  2021cites this paper
• miR-21 may Act as a Potential Mediator Between Inflammation and Abnormal Bone Formation in Ankylosing Spondylitis Based on TNF-α Concentration-Dependent Manner Through the JAK2/STAT3 Pathway

  2020cites this paper
• Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome.

  2020cites this paper
• Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients

  2020cites this paper
• MicroRNAs in ankylosing spondylitis: Function, potential and challenges

  2020cites this paper
• Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis

  2019cites this paper
• miR-17-5p Regulates Heterotopic Ossification by Targeting ANKH in Ankylosing Spondylitis

  2019influential citation
• Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis

  2019cites this paper
• Noncoding RNAs Involved in the Pathogenesis of Ankylosing Spondylitis

  2019cites this paper
• Association between Ankylosing Spondylitis and the miR-146a Polymorphisms a Samples of Iraqi Patients

  2019cites this paper
• Serum miR-21 expression correlates with radiographic progression but also low bone mineral density in patients with ankylosing spondylitis: a cross-sectional study

  2019cites this paper
• Epigenetics of autoimmune diseases

  2019cites this paper
• Identification of potential target genes for ankylosing spondylitis treatment

  2018cites this paper
• Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis

  2018cites this paper
• Expression and Metabolomic Profiling in Axial Spondyloarthritis

  2018cites this paper
• MicroRNA implications in the etiopathogenesis of ankylosing spondylitis

  2018cites this paper
• Genetic and epigenetic etiology of autoimmune diseases: lessons from twin studies

  2018cites this paper
• Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases.

  2017cites this paper
• New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications

  2017cites this paper
• The Role of MicroRNAS in Ankylosing Spondylitis

  2016cites this paper
• Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis

  2016cites this paper
• Differences in osteoclast activity between rheumatoid arthritis and ankylosing spondylitis

  2016cites this paper
• Epigenetic alterations underlying autoimmune diseases

  2016cites this paper
• Ankylosing spondylitis: beyond genome-wide association studies

  2016cites this paper
• Micro-Ribonucleic Acid Profiles From Microarray in Ankylosing Spondylitis.

  2016cites this paper
• Gene Expression Profiling Analysis of Patients With Ankylosing Spondylitis

  2015cites this paper
• Gene Expression Profiling Analysis of Patients With Ankylosing Spondylitis: Retracted

  2015cites this paper
• Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic Targets

  2015cites this paper